Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06936202

Effects of Spirulina Supplementation on Mental Health in Healthy Adults

Spirulina platensis is a form of cyanobacteria, a blue-green algae, and is a superfood most known for being rich in protein, vitamins and minerals, and healthful phytochemicals. Spirulina supports brain health through neuroprotection offered by its antioxidants, anti-inflammatory properties, and hormone regulation.

The aim of this study is to supplement healthy adults from a campus community with 3g of spirulina, daily, for 8 weeks to improve mood and mental acuity in comparison to receiving a placebo.

Recruiting

Interested in participating?

Request Info

Key information

Age range

16 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Spirulina is nutrient-dense with vitamins and minerals which provide antioxidants and anti-inflammatory mechanisms to help reduce oxidative stress and ROS activity. Preclinical studies have indicated Spirulina can reduce inflammatory cytokines, such as IL-1β, and reverse stress responses and oxidative damage in BDNF, nuclear factor erythroid 2-related factor (NRF2), and ultimately the phosphorylation of protein-kinase B (AKT), which promotes cell growth. In addition to these benefits, fatty acids, gamma-linolenic acid (GLA) and glycolipids, support gut health and the immune system. In combination, all these nutrients help increase neuroprotection and brain health.

It is evident that Spirulina supports brain health through neuroprotection, antioxidants, anti-inflammatory properties, and hormone regulation. Research supports Spirulina reversing neurodegenerative diseases due to several of these beneficial properties. There have been many studies that utilize Spirulina to improve cognitive function in Alzheimer's Disease, Parkinson's Disease, ulcerative colitis, IBD, fibromyalgia and even in TBI and Ischemic stroke.

Although many of these diseases have depressive symptoms, few of these studies have evaluated the impact of Spirulina on mood. Furthermore, no studies have been conducted relating depression and the cyanobacteria. It is possible that Spirulina supplements can be used to reduce feelings of hopelessness and lack of energy, by providing additional vitamins, minerals, amino acids, and fatty acids, on a daily basis. This study aims to compare spirulina and its improvement on mood, in health college students, by daily supplementation of 3g of Spirulina over a span of 8 weeks.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy adults
  • ages 18-65
  • no underlying chronic disease or acute conditions
  • no autoimmune conditions
  • do not consume alcohol in excess, smoke, use recreational drugs
  • does not follow restrictive diets
  • will be recruited from the ASU university campus.

Exclusion criteria

  • not have been clinically diagnosed with depression
  • not taking antidepressants, anxiety, or stress medications, or any other medications
  • drugs, or supplements that could influence mental capacities
  • not pregnant or breastfeeding
  • not a competitive athlete

Treatment and study plan

Spirulina capsules

Other

active intervention

Placebo

Other

no active ingredient

Primary outcomes

  1. POMS (profile of mood states questionnaire)

    Time frame: conducted at baseline and at week 8 (study's end)

    A validated measure consisting of 65 brief phrases, asking how they have personally felt over the last week, including today. The participants were asked to carefully rate their response on a 5-point Likert scale, ranging from 'not at all' to 'extremely'.

  2. Trail Making Test

    Time frame: conducted at baseline and at week 8 (study's end)

    The TMT consists of two iterations - versions A and B - and brief samples of each will be provided for the participant to practice prior to the longer, scored version. This is a timed paper and pencil test requiring the participant to connect a series of numbers and/or letters that are randomly arranged.

Study contacts

Contact information is provided by the study sponsor or research team.

Carol Johnston, PhD

CONTACT

[email protected]

16024962539

Sponsors and collaborators

Lead sponsor

Arizona State University

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 20, 2025
Registry last updated
Aug 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.